Medial temporal lobectomy is effective in improving seizure outcomes among patients with drug-resistant temporal lobe epilepsy.

Before the introduction of the measles vaccine in the 1960s, there were an estimated 400 to 500 deaths in the U.S. each year ...

"FDA approves Neurelis’ nasal spray for seizures" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has b ...

A new global study has found genetic changes that may make individuals with focal epilepsy less responsive to seizure ...

Focal cortical dysplasia (FCD) type 2 is a congenital malformation of the cerebral cortex that is often associated with ...

Focal cortical dysplasia (FCD) type 2 is a congenital malformation of the cerebral cortex that is often associated with difficult-to-treat epilepsy. In the affected areas, nerve cells and their layer ...

BOWIE, Md., April 16, 2025 (GLOBE NEWSWIRE) -- The Epilepsy Foundation of America is proud to announce the release of the Epilepsy & Seizure Safe Classrooms Toolkit, a comprehensive educational ...

Precision meets noninvasive treatment in the revolutionary approach known as focused ultrasound (FUS). Focused ultrasound is a new noninvasive therapeutic approach for people with either Parkinson’s ...

Certain common genetic changes might make some people with focal epilepsy less responsive to seizure medications, finds a new global study led by researchers at UCL and UTHealth Houston.

Certain common genetic changes might make some people with focal epilepsy less responsive to seizure medications, finds a new ...

As families across the country deal with trying to make ends meet, doctors are seeing some parents turning to dangerous ...